ABOUT DK
Founded in 2015 by Yulin Weng and headquartered in Suzhou, Jiangsu Province, China, DK Medtech is dedicated to enhancing patients’ quality of life through cutting-edge technologies and innovative medical solutions. With a comprehensive product portfolio spanning coronary, peripheral, and neurovascular interventions, we deliver high-quality therapeutic options for global patients.
Technological Leadership
As a pioneer in full-range vascular interventions, DK Medtech has developed over 10 balloon catheter types including conventional balloons, high-pressure balloons, scoring balloons, and drug-coated scoring balloons. Our proprietary Directional Scoring Technology demonstrates superior clinical benefits in coronary/peripheral scoring balloons and DCBs, outperforming imported counterparts in pre-market RCT studies. Strategic collaborations with Medtronic and Asahi Intecc further validate our market position.
Operational Excellence
With a 300+ multidisciplinary team, DK Medtech operates a 12,000㎡ global manufacturing center and 9,200㎡ R&D hub. Our achievements include:
– National Recognition: National High-tech Enterprise, Jiangsu Potential Unicorn, Suzhou Unicorn Cultivation Enterprise
– Industry Accolades: Top 100 Medical Innovations (2024), China Biopharma Leader TOP100 (2024), Venture50 Rising Star (2023)
– Certifications: ISO 13485, MDSAP, GB/T29490 Intellectual Property Compliance
Strategic Growth
Backed by premier investors including Qiming Venture Partners, Legend Capital, and CICC Capital, DK Medtech has secured six rounds of financing exceeding USD 100 million, accelerating global commercialization of our innovative pipeline.
corporate culture
Quality system
We have established a globally compliant quality management system, certified under:
– China Medical Device GMP
– ISO 13485:2016 & EN ISO 13485:2016 (Medical Device Quality Management System)
– Medical Device Single Audit Program (MDSAP)
– MDR (EU) 2017/745
– Japan FMDA Certificate
– Taiwan Medical Device Quality System Documentation (QSD)
DK Medtech has consistently excelled in audits by regulatory authorities and third-party notified bodies.
history
- Closed Series E Financing Round (Legend Capital, Qiming Venture Partners) raising hundreds of millions CNY
- Presented DELTA Trial clinical results at LINC 2024
- Renewed strategic collaboration with Medtronic on coronary innovations
- Obtained MDSAP Certification
- Awarded National Specialized and Sophisticated SME Pioneer title
- Received regulatory approval for DKutting LL™ Peripheral Scoring Balloon Catheter
- Signed neurovascular strategic partnership with Medtronic
- Launched Peripheral Drug-Coated Scoring Balloon and Rapid Exchange Balloon Catheter
- Obtained approval for Coronary Scoring Balloon
- Completed Series D Financing (CICC Capital, GTJA Investment) exceeding RMB 100 million
- Established partnerships with Medtronic (coronary DCBs) and Asahi Intecc (scoring balloons)
- Certified as National High-Tech Enterprise (2019)
- Launched DKaptain™ High-Pressure Balloon Kit (2021) and DKonquer™ Peripheral Balloon (2020)
- Founded in 2015 as Suzhou Industrial Park Technology Leader
- Secured ISO 13485 Certification (2017) and completed multi-round financing
- 2024
- 2023
- 2022
- 2019-2021
- 2015-2018
Global layout
Suzhou・ China
Headquarters Building 5, Xinhong Industrial Park, No. 9 Suhong West Road, Suzhou Industrial Park, Jiangsu, China
Suzhou・ China
Global Manufacturing Center No. A7 Building, 56 Yangfu Road,No. A7 Building Suzhou Industrial Park Jiangsu, China
Singapore
International Business Headquarters
